The Clinical Operations Team at Harpoon Therapeutics is responsible for the planning, execution, and management of clinical trials, ensuring that they adhere to regulatory requirements and timelines. This team oversees protocol development, site selection, patient recruitment, data collection, and monitoring of ongoing clinical studies, including the Phase 1 trial of HPN424 for prostate cancer. They work collaboratively with cross-functional teams to ensure the clinical development plan is executed efficiently and effectively, advancing the company's pipeline of T cell engager therapies.
View all